Literature DB >> 19845338

Lipophilic 2,5-disubstituted pyrroles from the marine sponge Mycale sp. inhibit mitochondrial respiration and HIF-1 activation.

Shui-Chun Mao1, Yang Liu, J Brian Morgan, Mika B Jekabsons, Yu-Dong Zhou, Dale G Nagle.   

Abstract

The lipid extract of the marine sponge Mycale sp. inhibited the activation of hypoxia-inducible factor-1 (HIF-1) in a human breast tumor T47D cell-based reporter assay. Bioassay-guided isolation and structure elucidation yielded 18 new lipophilic 2,5-disubstituted pyrroles and eight structurally related known compounds. The active compounds inhibited hypoxia-induced HIF activation with moderate potency (IC50 values <10 microM). Mechanistic studies revealed that the active compounds suppressed mitochondrial respiration by blocking NADH-ubiquinone oxidoreductase (complex I) at concentrations that inhibited HIF-1 activation. Under hypoxic conditions, reactive oxygen species produced by mitochondrial complex III are believed to act as a signal of cellular hypoxia that leads to HIF-1alpha protein induction and activation. By inhibiting electron transport (or delivery) to complex III under hypoxic conditions, lipophilic Mycale pyrroles appear to disrupt mitochondrial ROS-regulated HIF-1 signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845338      PMCID: PMC2868385          DOI: 10.1021/np900444m

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  39 in total

1.  New 5-alkylpyrrole-2-carboxaldehyde derivatives from the sponge Mycale tenuispiculata.

Authors:  U Venkatesham; M Rama Rao; Y Venkateswarlu
Journal:  J Nat Prod       Date:  2000-09       Impact factor: 4.050

2.  Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.

Authors:  David Lando; Daniel J Peet; Dean A Whelan; Jeffrey J Gorman; Murray L Whitelaw
Journal:  Science       Date:  2002-02-01       Impact factor: 47.728

3.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

4.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  Peloruside A: a potent cytotoxic macrolide isolated from the new zealand marine sponge Mycale sp.

Authors:  L M West; P T Northcote; C N Battershill
Journal:  J Org Chem       Date:  2000-01-28       Impact factor: 4.354

8.  Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

Authors:  H E Ryan; M Poloni; W McNulty; D Elson; M Gassmann; J M Arbeit; R S Johnson
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

9.  The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy.

Authors:  Annika Unruh; Anke Ressel; Hamid G Mohamed; Randall S Johnson; Roger Nadrowitz; Eckart Richter; Dörthe M Katschinski; Roland H Wenger
Journal:  Oncogene       Date:  2003-05-22       Impact factor: 9.867

10.  Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.

Authors:  Kylie A Hood; Lyndon M West; Berber Rouwé; Peter T Northcote; Michael V Berridge; St John Wakefield; John H Miller
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  6 in total

1.  Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors.

Authors:  Chalet Tan; Rita G de Noronha; Narra S Devi; Adnan A Jabbar; Stefan Kaluz; Yuan Liu; Suazette Reid Mooring; K C Nicolaou; Binghe Wang; Erwin G Van Meir
Journal:  Bioorg Med Chem Lett       Date:  2011-06-28       Impact factor: 2.823

2.  Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.

Authors:  Shaoman Yin; Stefan Kaluz; Narra S Devi; Adnan A Jabbar; Rita G de Noronha; Jiyoung Mun; Zhaobin Zhang; Purushotham R Boreddy; Wei Wang; Zhibo Wang; Thomas Abbruscato; Zhengjia Chen; Jeffrey J Olson; Ruiwen Zhang; Mark M Goodman; K C Nicolaou; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2012-08-24       Impact factor: 12.531

Review 3.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

4.  Kalkitoxin inhibits angiogenesis, disrupts cellular hypoxic signaling, and blocks mitochondrial electron transport in tumor cells.

Authors:  J Brian Morgan; Yang Liu; Veena Coothankandaswamy; Fakhri Mahdi; Mika B Jekabsons; William H Gerwick; Frederick A Valeriote; Yu-Dong Zhou; Dale G Nagle
Journal:  Mar Drugs       Date:  2015-03-20       Impact factor: 5.118

5.  First Report on Chitin in a Non-Verongiid Marine Demosponge: The Mycale euplectellioides Case.

Authors:  Sonia Żółtowska-Aksamitowska; Lamiaa A Shaala; Diaa T A Youssef; Sameh S Elhady; Mikhail V Tsurkan; Iaroslav Petrenko; Marcin Wysokowski; Konstantin Tabachnick; Heike Meissner; Viatcheslav N Ivanenko; Nicole Bechmann; Yvonne Joseph; Teofil Jesionowski; Hermann Ehrlich
Journal:  Mar Drugs       Date:  2018-02-20       Impact factor: 5.118

6.  Pyrrole Alkaloids from the Edible Mushroom Phlebopus portentosus with Their Bioactive Activities.

Authors:  Zhaocui Sun; Meigeng Hu; Zhonghao Sun; Nailiang Zhu; Junshan Yang; Guoxu Ma; Xudong Xu
Journal:  Molecules       Date:  2018-05-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.